Drug Type Small molecule drug |
Synonyms N 29, N29 |
Target |
Action antagonists |
Mechanism AR antagonists(Androgen Receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC20H19F3N4O3S |
InChIKeyWOGAVKOQNHDXFD-UHFFFAOYSA-N |
CAS Registry2719816-32-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Cancer | Discovery | China | 28 Sep 2024 |